A Taiwanese medical team has developed a new treatment for triple-negative breast cancer (TNBC) that tackles treatment-resistance, National Health Research Institutes (NHRI) president Sytwu Huey-kang (司徒惠康) told a news conference yesterday.
National Tsing Hua University (NTHU) Institute of Molecular and Cellular Biology professor Lily Wang (王慧菁), a member of the team made up of NHRI and NTHU researchers, said TNBC relies on chemotherapy drugs such as paclitaxel and currently cannot be treated by targeted therapy.
However, although people with this type of cancer have a five-year survival rate of 77 percent, there is a recurrence rate of 30 to 40 percent. Once the cancer returns, it often becomes resistant to paclitaxel, causing the survival rate to drop to just 8 to 12 percent, she said.
Photo: CNA
Drug resistance is caused by a protein in the body called KIF2C, a type of kinesin involved in cell division, Wang said, adding that when overly active in cancer cells, KIF2C helps them resist the effects of paclitaxel.
The new drug works by inhibiting the activity of KIF2C in cancer cells, she said.
The research team has applied the drug to treatment of ovarian cancer, endometrial cancer and cervical cancer, she added.
Hsieh Hsing-pang (謝興邦), director of the NHRI’s Institute of Biotechnology and Pharmaceutical Research, said the drug is the world’s first cell-penetrating small-molecule inhibitor of KIF2C.
It also demonstrates synergy when used in combination with paclitaxel, he added.
The drug is expected to be on the market in about five years, Hsieh said.
The team has received funding from the National Science and Technology Council this year to carry out preclinical testing, according to an NHRI statement.
The development of the new drug would be the cover story in next month’s edition of the international journal Developmental Cell, Sytwu said.
Breast cancer is the most common cancer among women, typically occurring between the ages of 60 and 64, Wang said, adding that TNBC accounts for about 10 to 15 percent of all breast cancer cases, with an average onset age of 46.
Notably, 20 percent of TNBC cases occur in women younger than 40, she added.
Organizing one national referendum and 26 recall elections targeting Chinese Nationalist Party (KMT) legislators could cost NT$1.62 billion (US$55.38 million), the Central Election Commission said yesterday. The cost of each recall vote ranges from NT$16 million to NT$20 million, while that of a national referendum is NT$1.1 billion, the commission said. Based on the higher estimate of NT$20 million per recall vote, if all 26 confirmed recall votes against KMT legislators are taken into consideration, along with the national referendum on restarting the Ma-anshan Nuclear Power Plant, the total could be as much as NT$1.62 billion, it said. The commission previously announced
The Ministry of Foreign Affairs (MOFA) yesterday welcomed NATO Secretary-General Mark Rutte’s remarks that the organization’s cooperation with Indo-Pacific partners must be deepened to deter potential threats from China and Russia. Rutte on Wednesday in Berlin met German Chancellor Friedrich Merz ahead of a ceremony marking the 70th anniversary of Germany’s accession to NATO. He told a post-meeting news conference that China is rapidly building up its armed forces, and the number of vessels in its navy outnumbers those of the US Navy. “They will have another 100 ships sailing by 2030. They now have 1,000 nuclear warheads,” Rutte said, adding that such
The cosponsors of a new US sanctions package targeting Russia on Thursday briefed European allies and Ukraine on the legislation and said the legislation would also have a deterrent effect on China and curb its ambitions regarding Taiwan. The bill backed by US senators Lindsey Graham and Richard Blumenthal calls for a 500 percent tariff on goods imported from countries that buy Russian oil, gas, uranium and other exports — targeting nations such as China and India, which account for about 70 percent of Russia’s energy trade, the bankroll of much of its war effort. Graham and Blumenthal told The Associated Press
Tropical Storm Nari is not a threat to Taiwan, based on its positioning and trajectory, the Central Weather Administration (CWA) said yesterday. Nari has strengthened from a tropical depression that was positioned south of Japan, it said. The eye of the storm is about 2,100km east of Taipei, with a north-northeast trajectory moving toward the eastern seaboard of Japan, CWA data showed. Based on its current path, the storm would not affect Taiwan, the agency said.
RSS